KMDA Projected Dividend Yield
Ord/Kamada Ltd ( NASDAQ : KMDA )Kamada is a plasma-derived biopharmaceutical company focused on orphan indications, with an existing marketed product portfolio and a late-stage product pipeline. Co. uses its platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived immune globulins. Co.'s activity is divided into two operating segments: Proprietary Products, which includes the development, manufacturing, sales and distribution of plasma-derived protein therapeutics; and Distribution, which distributes imported drug products in Israel that are manufactured by third parties. 20 YEAR PERFORMANCE RESULTS |
KMDA Dividend History Detail KMDA Dividend News KMDA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |